Pharmaceutical Raw Materials CAS 100986-85-4 Levofloxacin Hemihydrate/Levofloxacin Powder

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: HNB-171
• Transport Package: Aluminium Foil Bag, Cardboard Drum
• Trademark: HNB-Biotech
• Origin: Shaanxi, China
• Production Capacity: 50000kg/Month

Product Description

Pharmaceutical Raw Materials CAS 100986-85-4 Levofloxacin Hemihydrate/Levofloxacin Powder

Product name	Levofloxacin
Cas No.	100986-85-4
Molecular Formula	C18H20FN3O4
Appearance	Pale yellow powder

Levofloxacin, a synthetic fluoroquinolone, is an antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.Target: AntibacterialLevofloxacin reduced bacterial load compared with placebo by 4.9-fold (95% confidence interval, 1.4-25.7; P=0.02) at day 7 but had no effect at any point on any marker of neutrophilic airway inflammation. In patients with a baseline bacterial load of more than 10(6) cfu/mL, levofloxacin treatment was associated with a 26.5% (95% confidence interval, 1.8%-51.3%; P=0.04) greater reduction in the percentage neutrophil count compared with placebo at day 7. Levofloxacin was found to significantly improve the clinical and microbiological parameters in CP individuals. A 30-day course of levofloxacin does not significantly improve BK viral load reduction or allograft function when used in addition to overall reduction of immunosuppression.